Effect of iron therapy on red cell indices and hemoglobin subtypes on patients with beta-thalassemia trait who developed iron-deficiency anemia: a tertiary center experience

Background The combination of beta-thalassemia trait (BTT) and iron-deficiency anemia (IDA) is an interesting common issue in our country. However, treatment of this condition is challenging. Objectives This prospective observational study was designed to evaluate the effect of oral iron therapy on...

Full description

Bibliographic Details
Main Authors: Sawsan M Moeen, Ahmad F Thabet, Marwa M Thabet
Format: Article
Language:English
Published: SpringerOpen 2019-01-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=741;epage=745;aulast=Moeen
_version_ 1828838532273143808
author Sawsan M Moeen
Ahmad F Thabet
Marwa M Thabet
author_facet Sawsan M Moeen
Ahmad F Thabet
Marwa M Thabet
author_sort Sawsan M Moeen
collection DOAJ
description Background The combination of beta-thalassemia trait (BTT) and iron-deficiency anemia (IDA) is an interesting common issue in our country. However, treatment of this condition is challenging. Objectives This prospective observational study was designed to evaluate the effect of oral iron therapy on red cell indices, iron status, and hemoglobin A2 levels in patients with BTT who developed IDA. Patients and methods A total of 50 patients with BTT who developed IDA were included. A complete blood count, iron status, and follow-up hemoglobin electrophoresis by high-performance liquid chromatography were done. The patients with BTT received oral iron therapy of 60 mg elemental iron three times/day for a period of 5 months, and the investigations were repeated after 3 and 5 months of treatment. Results There was a statistically significant increase in hemoglobin level (P<0.001 each), mean corpuscular volume (P<0.001 each), mean corpuscular hemoglobin (P=0.004 and P<0.001, respectively), mean corpuscular hemoglobin concentration (P=0.007 and P=0.001, respectively), serum iron (P<0.001 each), serum ferritin (P<0.001 each), and hemoglobin A2 levels (P=0.001 and P=0.005, respectively), whereas significant decrease in the total iron-binding capacity (P=0.001, and P=0.005, respectively) after the third and fifth month of oral iron therapy. Conclusion It is important to suspect, recognize, and correct IDA in patients with BTT and to repeat hemoglobin electrophoresis after iron therapy.
first_indexed 2024-12-12T19:04:32Z
format Article
id doaj.art-f90f59bfceed45b1849ad7737eb68e69
institution Directory Open Access Journal
issn 1110-7782
2090-9098
language English
last_indexed 2024-12-12T19:04:32Z
publishDate 2019-01-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Internal Medicine
spelling doaj.art-f90f59bfceed45b1849ad7737eb68e692022-12-22T00:15:00ZengSpringerOpenThe Egyptian Journal of Internal Medicine1110-77822090-90982019-01-0131474174510.4103/ejim.ejim_38_19Effect of iron therapy on red cell indices and hemoglobin subtypes on patients with beta-thalassemia trait who developed iron-deficiency anemia: a tertiary center experienceSawsan M MoeenAhmad F ThabetMarwa M ThabetBackground The combination of beta-thalassemia trait (BTT) and iron-deficiency anemia (IDA) is an interesting common issue in our country. However, treatment of this condition is challenging. Objectives This prospective observational study was designed to evaluate the effect of oral iron therapy on red cell indices, iron status, and hemoglobin A2 levels in patients with BTT who developed IDA. Patients and methods A total of 50 patients with BTT who developed IDA were included. A complete blood count, iron status, and follow-up hemoglobin electrophoresis by high-performance liquid chromatography were done. The patients with BTT received oral iron therapy of 60 mg elemental iron three times/day for a period of 5 months, and the investigations were repeated after 3 and 5 months of treatment. Results There was a statistically significant increase in hemoglobin level (P<0.001 each), mean corpuscular volume (P<0.001 each), mean corpuscular hemoglobin (P=0.004 and P<0.001, respectively), mean corpuscular hemoglobin concentration (P=0.007 and P=0.001, respectively), serum iron (P<0.001 each), serum ferritin (P<0.001 each), and hemoglobin A2 levels (P=0.001 and P=0.005, respectively), whereas significant decrease in the total iron-binding capacity (P=0.001, and P=0.005, respectively) after the third and fifth month of oral iron therapy. Conclusion It is important to suspect, recognize, and correct IDA in patients with BTT and to repeat hemoglobin electrophoresis after iron therapy.http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=741;epage=745;aulast=Moeenanemiabeta-thalassemia traitiron deficiencyserum ferritin
spellingShingle Sawsan M Moeen
Ahmad F Thabet
Marwa M Thabet
Effect of iron therapy on red cell indices and hemoglobin subtypes on patients with beta-thalassemia trait who developed iron-deficiency anemia: a tertiary center experience
The Egyptian Journal of Internal Medicine
anemia
beta-thalassemia trait
iron deficiency
serum ferritin
title Effect of iron therapy on red cell indices and hemoglobin subtypes on patients with beta-thalassemia trait who developed iron-deficiency anemia: a tertiary center experience
title_full Effect of iron therapy on red cell indices and hemoglobin subtypes on patients with beta-thalassemia trait who developed iron-deficiency anemia: a tertiary center experience
title_fullStr Effect of iron therapy on red cell indices and hemoglobin subtypes on patients with beta-thalassemia trait who developed iron-deficiency anemia: a tertiary center experience
title_full_unstemmed Effect of iron therapy on red cell indices and hemoglobin subtypes on patients with beta-thalassemia trait who developed iron-deficiency anemia: a tertiary center experience
title_short Effect of iron therapy on red cell indices and hemoglobin subtypes on patients with beta-thalassemia trait who developed iron-deficiency anemia: a tertiary center experience
title_sort effect of iron therapy on red cell indices and hemoglobin subtypes on patients with beta thalassemia trait who developed iron deficiency anemia a tertiary center experience
topic anemia
beta-thalassemia trait
iron deficiency
serum ferritin
url http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=741;epage=745;aulast=Moeen
work_keys_str_mv AT sawsanmmoeen effectofirontherapyonredcellindicesandhemoglobinsubtypesonpatientswithbetathalassemiatraitwhodevelopedirondeficiencyanemiaatertiarycenterexperience
AT ahmadfthabet effectofirontherapyonredcellindicesandhemoglobinsubtypesonpatientswithbetathalassemiatraitwhodevelopedirondeficiencyanemiaatertiarycenterexperience
AT marwamthabet effectofirontherapyonredcellindicesandhemoglobinsubtypesonpatientswithbetathalassemiatraitwhodevelopedirondeficiencyanemiaatertiarycenterexperience